Survey Experiment to Estimate Level of Mental Illness Stigma Based on Condition and Gender

Measuring Level of Mental Illness Stigma Based on Condition and Gender

This study aims to measure levels of mental illness stigma based on condition and gender of the participants and individual portrayed with mental illness.

Study Overview

• Status: Completed
• Conditions: Mental Illness; Stigma, Social
• Intervention / Treatment: Other: Survey questionnaire

Detailed Description

This study aims to measure levels of mental illness stigma based on condition and gender of the participants and individual portrayed with mental illness. This study utilizes eight vignettes portraying different mental illnesses and genders to measure the levels of mental illness stigma in the general community in rural Uganda.

• Study Type: Interventional
• Enrollment (Actual): 379
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Uganda
  • Iganga, Uganda
    • Empowerment to Heal - Uganda

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• All adults who consider Buyende District their primary residence and who are capable of providing consent

Exclusion Criteria:

• Minors younger than 18 years of age
• Persons who do not consider Buyende District their primary place of residence

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

8

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Experimental: V1: Woman with Major Depressive Disorder; Depicting a young woman with symptomatic major depressive disorder	Other: Survey questionnaire; The intervention is being assigned to one of the 8 different versions of the survey vignette.
Experimental: Experimental: V2: Man with Major Depressive Disorder; Depicting a young man with symptomatic major depressive disorder	Other: Survey questionnaire; The intervention is being assigned to one of the 8 different versions of the survey vignette.
Experimental: Experimental: V3: Man with Generalized Anxiety Disorder; Depicting a young man with symptomatic generalized anxiety disorder	Other: Survey questionnaire; The intervention is being assigned to one of the 8 different versions of the survey vignette.
Experimental: Experimental: V4: Woman with Generalized Anxiety Disorder; Depicting a young woman with symptomatic generalized anxiety disorder	Other: Survey questionnaire; The intervention is being assigned to one of the 8 different versions of the survey vignette.
Experimental: Experimental: V5: Woman with Schizophrenia; Depicting a young woman with symptomatic schizophrenia	Other: Survey questionnaire; The intervention is being assigned to one of the 8 different versions of the survey vignette.
Experimental: Experimental: V6: Man with Schizophrenia; Depicting a young man with symptomatic schizophrenia	Other: Survey questionnaire; The intervention is being assigned to one of the 8 different versions of the survey vignette.
Experimental: Experimental: V7: Woman with Alcohol Use Disorder; Depicting a young woman with symptomatic alcohol use disorder	Other: Survey questionnaire; The intervention is being assigned to one of the 8 different versions of the survey vignette.
Experimental: Experimental: V8: Man with Alcohol Use Disorder; Depicting a young man with symptomatic alcohol use disorder	Other: Survey questionnaire; The intervention is being assigned to one of the 8 different versions of the survey vignette.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Level of acceptance for the individual depicted in the vignette as measured by PERSONAL ACCEPTANCE SCALE	The PAS is a 9-item questionnaire targeted to public stigma, the "negative attitudes, beliefs, and behaviors held within a community" against individuals with mental illness. Each yes adds one point to the scale, and five questions from each scale were reverse-scored to match the direction of the scale. The total number of points was divided by the number of questions (nine) and multiplied by ten to generate numbers between zero and ten for comparison purposes to the Broad Acceptance Scale. Higher scores indicated more acceptance and less stigma towards mental illness, while lower scores indicated less acceptance and more stigma towards mental illness.	Study period. For each interview, approximately 60 minutes.
Level of acceptance for the individual depicted in the vignette as measured by BROAD ACCEPTANCE SCALE	The BAS is a 9-item questionnaire targeted to structural stigma, the "societal-level conditions, cultural norms, and institutional practices that constrain the opportunities, resources, and wellbeing" for individuals with mental illness. Each yes adds one point to the scale, and five questions from each scale were reverse-scored to match the direction of the scale. There were ten questions, therefore it generated a score between zero and ten. Higher scores indicated more acceptance and less stigma towards mental illness, while lower scores indicated less acceptance and more stigma towards mental illness.	Study period. For each interview, approximately 60 minutes.

Collaborators and Investigators

• Sponsor: Yale University
• Collaborators: Empower Through Health

Study record dates

Study Major Dates

• Study Start (Actual): June 15, 2023
• Primary Completion (Actual): September 15, 2023
• Study Completion (Actual): September 15, 2023

Study Registration Dates

• First Submitted: February 14, 2024
• First Submitted That Met QC Criteria: February 19, 2024
• First Posted (Actual): February 28, 2024

Study Record Updates

• Last Update Posted (Actual): June 10, 2024
• Last Update Submitted That Met QC Criteria: June 7, 2024
• Last Verified: June 1, 2024

More Information

Terms related to this study

• Keywords: stigma; mental illness; low-income country
• Additional Relevant MeSH Terms: Mental Disorders
• Other Study ID Numbers: 2000034605_a

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No